Amgen (AMGN) Notes Payables (2009 - 2014)

Amgen (AMGN) has reported Notes Payables for 5 consecutive years, with $2.5 billion the latest figure, recorded in Q1 2014.

• In Q1 2014, Notes Payables rose 35685.71% year-over-year to $2.5 billion; the TTM figure through Mar 2014 stood at $2.5 billion (up 35685.71% YoY), while the FY2013 annual figure was $2.5 billion, changed 0.4% from the prior year.
• Notes Payables came in at $2.5 billion for Q1 2014 at Amgen, roughly flat from $2.5 billion in the prior quarter.
• The five-year high for Notes Payables was $2.5 billion in Q4 2013, with the low at $7.0 million in Q1 2013.
• Average Notes Payables over 4 years is $1.2 billion, with a median of $300.0 million recorded in 2011.
• Across the five-year window, Notes Payables slumped 99.55% in 2013 and jumped 35685.71% in 2014, its largest moves.
• Year by year, Notes Payables stood at $84.0 million in 2011, then jumped by 2870.24% to $2.5 billion in 2012, then advanced by 0.4% to $2.5 billion in 2013, then changed by 0.0% to $2.5 billion in 2014.
• According to Business Quant data, Notes Payables over the past three periods registered $2.5 billion, $2.5 billion, and $11.0 million for Q1 2014, Q4 2013, and Q3 2013 respectively.